In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine

A Muthukumar, M Narasimhan, QZ Li… - Circulation, 2021 - Am Heart Assoc
A Muthukumar, M Narasimhan, QZ Li, L Mahimainathan, I Hitto, F Fuda, K Batra, X Jiang…
Circulation, 2021Am Heart Assoc
A 52-year-old man presented to the emergency department≈ 90 min after the onset of
substernal chest pain. Three days before presentation, he received his second dose of
mRNA-1273 (Moderna) vaccine for coronavirus disease 2019 (COVID-19), and the next day
had a severe reaction that he described as being the “worst he had ever felt.” He had
subjective high fevers, shaking chills, myalgias, and a headache. These symptoms largely
resolved by the third day after vaccination except for a positional headache that was unusual …
A 52-year-old man presented to the emergency department≈ 90 min after the onset of substernal chest pain. Three days before presentation, he received his second dose of mRNA-1273 (Moderna) vaccine for coronavirus disease 2019 (COVID-19), and the next day had a severe reaction that he described as being the “worst he had ever felt.” He had subjective high fevers, shaking chills, myalgias, and a headache. These symptoms largely resolved by the third day after vaccination except for a positional headache that was unusual for him. On the morning of hospitalization, he walked 3 to 4 miles and felt fine. Later that day, while in a meeting, he developed persistent midsternal chest discomfort without radiation, prompting him to seek evaluation in a university hospital emergency department. The pain subsided spontaneously after approximately 3 hours. He had no associated dyspnea, palpitations, dizziness, fever, chills, or myalgia. The patient had a past medical history of hypertension, hypercholesterolemia, obstructive sleep apnea treated with an oral appliance, and minor elevations in liver function tests attributed to possible hepatic steatosis. A recent screening coronary artery calcium scan demonstrated coronary artery calcium at the 81st percentile for age and sex. The patient had no previous history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. His medications included aspirin 81 mg, simvastatin 40 mg, ezetimibe 10 mg, and lisinopril 10 mg daily, and he took no supplements. He drank alcohol socially and denied use of tobacco and all recreational drugs. On physical examination, the following vital signs were recorded: oral temperature 36.8 C, pulse 73/min, blood pressure 124/76, and respiratory rate 18/min, and his oxygen saturation was 100% on room air. Pulmonary and cardiac examinations were normal without a pericardial friction rub. The remainder of his physical examination was normal. In the emergency department, his initial ECG showed sinus rhythm with left axis deviation and incomplete right bundle-branch block without ST or T wave changes (Figure 1A). His initial high-sensitivity cardiac troponin I was 2768 ng/L. Point-of-care echocardiogram showed normal left ventricular function and volumes, and no wall motion abnormalities. Urgent coronary angiography showed mild nonobstructive coronary artery disease with no stenoses or visible thrombus and no evidence of coronary embolism or dissection (Figure 1B and 1C). His initial laboratory panel revealed normal white blood cells 6.3× 109/L (76% polymorphonuclear leukocytes, 14% lymphocytes, 9% monocytes, 0.5% eosinophils, and 0.2% basophils), hemoglobin 14.9 g/L, and platelets 207× 109/L. Chemistries were remarkable for glucose of 172 mg/dL, but creatinine 0.87 mg/dL and alanine aminotrans-
Am Heart Assoc